SCP
AGN

Steamboat Capital Partners’s Allergan plc AGN Stock Holding History

Steamboat Capital Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-49,667
Closed -$8.8M – 59
2020
Q1 		$8.8M Buy
49,667
+280
+0.6% +$52.7K 1.73% 25
2019
Q4 		$9.44M Sell
49,387
-896
-2% -$162K 2.67% 18
2019
Q3 		$8.46M Buy
50,283
+283
+0.6% +$46.1K 2.61% 19
2019
Q2 		$8.37M Buy
+50,000
New +$6.92M 2.2% 22

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Steamboat Capital Partners's AGN Position: Q2 2020 in Review

Steamboat Capital Partners sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 49,667 shares — an estimated $8.8M sold.

Steamboat Capital Partners first reported a position in AGN in Q2 2019 and held it in 4 quarters. The position peaked at $9.44M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Steamboat Capital Partners reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Steamboat Capital Partners sold 49,667 Allergan plc shares in Q2 2020, an estimated $8.8M.
  • Steamboat Capital Partners first reported a position in Allergan plc in Q2 2019 and held it in 4 quarters.
  • Steamboat Capital Partners's Allergan plc position peaked at $9.44M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Steamboat Capital Partners's 13F filing for Q2 2020, filed 14 Aug 2020.